Literature DB >> 26235196

Impact of urinary tract infections on short-term kidney graft outcome.

M Bodro1, G Sanclemente2, I Lipperheide2, M Allali2, F Marco3, J Bosch3, F Cofan4, M J Ricart4, N Esforzado4, F Oppenheimer4, A Moreno2, C Cervera5.   

Abstract

Urinary tract infections (UTIs) are frequent after renal transplantation, but their impact on short-term graft outcome is not well established. All kidney transplants performed between July 2003 and December 2010 were investigated to evaluate the impact of UTI on graft function at 1 year after transplantation. Of 867 patients who received a kidney transplant, 184 (21%) developed at least one episode of UTI, at a median of 18 days after transplantation. The prevalence of acute graft pyelonephritis (AGP) was 15%. The most frequent pathogens identified were Escherichia coli, Klebsiella species, and Pseudomonas aeruginosa, 37% of which were considered to be multidrug-resistant strains. Thirty-eight patients (4%) lost their grafts, 225 patients (26%) had graft function impairment and the 1-year mortality rate was 3%; however, no patient died as a consequence of a UTI. Surgical re-intervention and the development of at least one episode of AGP were independently associated with 1-year graft function impairment. Moreover, the development of at least one episode of AGP was associated with graft loss at 1 year. Patients with AGP caused by a resistant strain had graft function impairment more frequently, although this difference did not reach statistical significance (53% vs. 36%, p 0.07). Neither asymptomatic bacteriuria nor acute uncomplicated UTI were associated with graft function impairment in multivariate analysis. To conclude, UTIs are frequent in kidney transplant recipients, especially in the early post-transplantation period. Although AGP was significantly associated with kidney graft function impairment and 1-year post-transplantation graft loss, lower UTIs did not affect graft function.
Copyright © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Acute graft pyelonephritis; graft survival; impaired graft function; kidney transplantation; urinary tract infections

Mesh:

Year:  2015        PMID: 26235196     DOI: 10.1016/j.cmi.2015.07.019

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  12 in total

1.  Efficacy and safety of oral fosfomycin for asymptomatic bacteriuria in kidney transplant recipients: Results from a Spanish multicenter cohort.

Authors:  María Ruiz-Ruigómez; Mario Fernández-Ruiz; José Tiago Silva; Elisa Vidal; Julia Origüen; Antonia Calvo-Cano; Enrique Luna-Huerta; Esperanza Merino; Domingo Hernández; Cristina Jironda-Gallegos; Rosa Escudero-Sánchez; Francesca Gioia; Antonio Moreno; Cristina Roca; Elisa Cordero; Darío Janeiro; Beatriz Sánchez-Sobrino; María Milagro Montero; Dolores Redondo; Francisco Javier Candel; Isabel Pérez-Flores; Carlos Armiñanzas; Claudia González-Rico; María Carmen Fariñas; Emilio Rodrigo; Belén Loeches; María O López-Oliva; Miguel Montejo; Ricardo Lauzurica; Juan Pablo Horcajada; Julio Pascual; Amado Andrés; José María Aguado; Francisco López-Medrano
Journal:  Antimicrob Agents Chemother       Date:  2021-02-08       Impact factor: 5.191

2.  Analysis of risk factors for early urinary tract infection after kidney transplantation.

Authors:  Zheng-Zheng Ma; Li Li; Yan-Xia Han; Ya-Dong Duan; Wei-Zhen Wang; Mei-E Niu
Journal:  Transl Androl Urol       Date:  2020-10

3.  Increased resistance of gram-negative urinary pathogens after kidney transplantation.

Authors:  Johannes Korth; Julia Kukalla; Peter-Michael Rath; Sebastian Dolff; Marco Krull; Hana Guberina; Anja Bienholz; Benjamin Wilde; Stefan Becker; Birgit Ross; Olympia Evdoxia Anastasiou; Andreas Kribben; Oliver Witzke
Journal:  BMC Nephrol       Date:  2017-05-19       Impact factor: 2.388

4.  Male kidney allograft recipients at risk for urinary tract infection?

Authors:  Gerold Thölking; Katharina Schuette-Nuetgen; Thomas Vogl; Ulrich Dobrindt; Barbara C Kahl; Marcus Brand; Hermann Pavenstädt; Barbara Suwelack; Raphael Koch; Stefan Reuter
Journal:  PLoS One       Date:  2017-11-16       Impact factor: 3.240

5.  Bacterial urinary tract infection among adult renal transplant recipients at St. Paul's hospital millennium medical college, Addis Ababa, Ethiopia.

Authors:  Teklehaimanot Kiros; Daniel Asrat; Zeleke Ayenew; Estifanos Tsige
Journal:  BMC Nephrol       Date:  2019-07-31       Impact factor: 2.388

6.  Perioperative prophylaxis with ertapenem reduced infections caused by extended-spectrum betalactamase-producting Enterobacteriaceae after kidney transplantation.

Authors:  Gemma Sanclemente; Marta Bodro; Carlos Cervera; Laura Linares; Frederic Cofán; Francesc Marco; Jordi Bosch; Federico Oppenheimer; Fritz Dieckmann; Asunción Moreno
Journal:  BMC Nephrol       Date:  2019-07-22       Impact factor: 2.388

7.  Urinary Tract Infections in Kidney Transplant Recipients-Is There a Need for Antibiotic Stewardship?

Authors:  Jens Strohaeker; Victoria Aschke; Alfred Koenigsrainer; Silvio Nadalin; Robert Bachmann
Journal:  J Clin Med       Date:  2021-12-31       Impact factor: 4.241

8.  Retrospective Analysis of the Risk Factors of Perioperative Bacterial Infection and Correlation with Clinical Prognosis in Kidney Transplant Recipients.

Authors:  Fang Cheng; Qiang Li; Jinglin Wang; Zhendi Wang; Fang Zeng; Yu Zhang
Journal:  Infect Drug Resist       Date:  2022-04-28       Impact factor: 4.177

Review 9.  Overview on urinary tract infection, bacterial agents, and antibiotic resistance pattern in renal transplant recipients.

Authors:  Xiuchun Zhang; Hui Gao; Juan Fu; Feng Lin; Azad Khaledi
Journal:  J Res Med Sci       Date:  2021-03-31       Impact factor: 1.852

10.  CMV meningitis associated with dimethyl fumarate therapy-induced lymphopenia in a multiple sclerosis patient.

Authors:  Ann-Kathrin Kogel; Ralf Gold; Ruth Schneider
Journal:  J Neurol       Date:  2021-06-27       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.